Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases-Reference-Cited by-同舟云学术

Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases

Published:2024-07 Issue: Volume:136 Page:112276
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Asano Yohei^ORCID,Hayashi Katsuhiro,Takeuchi Akihiko,Kato Satoshi,Miwa Shinji,Taniguchi Yuta,Okuda Miho,Matsumoto Isao,Yano Seiji,Demura Satoru^ORCID

Publisher

Elsevier BV

Reference50 articles.

1. Prognostic role of modified Glasgow Prognostic score in elderly patients with non-small cell lung cancer treated with anti-PD-1 antibodies;Tanaka;Respir. Investig.,2023

2. F. Bray J. Ferlay I. Soerjomataram R.L. Siegel L.A. Torre A. Jemal Global cancer statistics, GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 68 2018 2018 394 424 10.3322/caac.21492.

3. Mechanisms of bone metastasis;Roodman;N. Engl. J. Med.,2004

4. Incidence, consequences and treatment of bone metastases in breast cancer patients-Experience from a single cancer centre;Kuchuk;J. Bone Oncol.,2013

5. Metastatic sites as predictors in advanced NSCLC treated with PD-1 inhibitors: a systematic review and meta-analysis;Huang;Hum. Vaccin. Immunother.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP;Biomolecules and Biomedicine;2024-07-14